Childhood asthma is a chronic lung condition that affects millions of children worldwide, causing airways to become inflamed and narrowed, making it difficult to breathe. While asthma cannot be cured, effective treatments and careful management can help children lead active, healthy lives with well-controlled symptoms.

How Treatment Helps Children with Asthma

The main goals when treating childhood asthma focus on improving your child’s daily quality of life. Treatment aims to reduce troublesome symptoms like coughing, wheezing, and shortness of breath that can interrupt sleep, play, and school activities. Doctors work to prevent chronic symptoms from limiting your child’s ability to participate in physical activities and sports. Another important goal is maintaining near-normal lung function so your child can breathe comfortably during daily activities.^[1]

Treatment also focuses on reducing risk. This means preventing recurrent asthma attacks (sudden worsening of symptoms), minimizing emergency room visits and hospitalizations, and preventing progressive loss of lung function over time. For children specifically, treatment aims to prevent reduced lung growth and provide effective medications with minimal or no adverse effects. The approach recognizes that asthma varies from child to child, and even in the same child over time, so treatment plans must be flexible and regularly adjusted.^[2]

The treatment plan depends on several factors including your child’s age, how severe the asthma is, how often symptoms occur, and what triggers make the asthma worse. Medical societies have developed comprehensive guidelines to help doctors provide consistent, evidence-based care. These guidelines emphasize four main components: regular assessment and monitoring, controlling environmental factors that trigger symptoms, appropriate medication therapy, and thorough education for children and their families.^[3]

Many children can achieve excellent asthma control with proper treatment. This means they can sleep through the night without coughing or wheezing, avoid missing school, participate fully in sports and physical activities, and use quick-relief medications infrequently. Research continues into new therapies that may offer even better control for children who struggle with severe or difficult-to-manage asthma.^[4]

Standard Treatment Approaches for Childhood Asthma

Standard asthma treatment follows a stepwise approach, meaning doctors start with the level of therapy that matches the severity of your child’s symptoms, then adjust up or down based on how well the asthma is controlled. This approach ensures children receive neither too little treatment (leaving symptoms uncontrolled) nor too much treatment (with unnecessary medication side effects). The treatment strategy includes both quick-relief medications for immediate symptom relief and long-term controller medications for preventing symptoms.^[5]

Quick-Relief Medications

Short-acting beta2-agonists are the preferred quick-relief medications for childhood asthma. The most commonly prescribed drug in this class is albuterol, though levalbuterol is another option. These medications work by relaxing the muscles around the airways, allowing them to open up and making breathing easier within minutes. They are used when your child experiences symptoms like wheezing, coughing, or chest tightness, and can also be given before exercise to prevent exercise-induced symptoms.^[6]

These quick-relief drugs are typically delivered through a metered-dose inhaler (a small handheld device that releases a measured dose of medication) with a spacer device (a tube that helps get more medication into the lungs), or through a nebulizer (a machine that turns liquid medication into a fine mist that can be breathed in through a mask or mouthpiece). For young children who cannot coordinate their breathing with an inhaler, nebulizers are often easier to use. The medication usually begins working within 5 to 15 minutes and lasts for 4 to 6 hours.^[7]

While these medications are very effective for immediate relief, frequent need for them (more than twice per week for symptom relief) suggests that asthma is not well controlled and that long-term controller medications should be started or adjusted. Overuse of quick-relief medications without addressing underlying inflammation can be dangerous and is a sign of poorly controlled asthma.^[8]

Long-Term Controller Medications

Inhaled corticosteroids are the most effective long-term medications for controlling childhood asthma. These anti-inflammatory medications work by reducing swelling and irritation in the airways, making them less sensitive to triggers. Common examples include fluticasone, budesonide, beclomethasone, and mometasone. Unlike oral steroids, inhaled corticosteroids deliver medication directly to the lungs, which means lower doses can be used and side effects are minimal.^[9]

These medications must be taken daily, even when your child feels well, because they work by preventing inflammation rather than treating symptoms after they occur. It may take several weeks of regular use before you notice the full benefit. Proper inhaler technique is critical for these medications to work effectively. After using an inhaled corticosteroid, children should rinse their mouth with water and spit it out to reduce the risk of thrush (a yeast infection in the mouth) and other local side effects.^[10]

Long-acting beta2-agonists such as formoterol and salmeterol are sometimes added to inhaled corticosteroids when asthma is not well controlled with steroids alone. These medications work similarly to short-acting beta2-agonists but last 12 hours or longer. They should never be used alone without an inhaled corticosteroid. Many medications combine an inhaled corticosteroid with a long-acting beta2-agonist in a single inhaler for convenience.^[11]

Leukotriene modifiers are oral medications taken as pills or chewable tablets once daily. The most commonly prescribed medication in this class is montelukast. These drugs work by blocking leukotrienes, which are chemicals in the body that cause airway inflammation, mucus production, and tightening of airway muscles. Leukotrienes are approximately 1,000 times more potent than histamine in causing inflammation. Leukotriene modifiers can be used alone for mild asthma or added to inhaled corticosteroids for better control. They are particularly helpful for children whose asthma is triggered by allergies or exercise.^[12]

Cromolyn sodium and nedocromil are older medications that prevent airways from becoming inflamed. These are inhaled medications that must be taken regularly to prevent symptoms. They have an excellent safety profile with very few side effects, making them options for children with mild asthma, though they are less potent than inhaled corticosteroids and are used less commonly today.^[13]

Theophylline is an oral medication that has been used for decades to treat asthma. It works by relaxing airway muscles and reducing inflammation. However, it requires careful monitoring through blood tests to ensure the dose is in the safe and effective range, and it can interact with many other medications. Because of these complications and the availability of more effective treatments, theophylline is rarely used as a first-choice medication for children today.^[14]

Medications for Asthma Attacks

When children experience severe asthma attacks, additional treatments beyond short-acting beta2-agonists may be necessary. Ipratropium is an anticholinergic medication that can be combined with albuterol in a nebulizer for severe attacks. It works by a different mechanism to further relax and open the airways.^[15]

Oral or injected corticosteroids such as prednisone, prednisolone, or methylprednisolone are sometimes prescribed for short courses (typically 3 to 10 days) during asthma attacks to quickly reduce severe inflammation. These systemic steroids are more potent than inhaled steroids but also have more potential side effects if used frequently or long-term. They may cause increased appetite, mood changes, stomach upset, and temporary effects on blood sugar and immune function. However, short courses are generally safe and can prevent hospitalizations.^[16]

Duration and Adjustment of Therapy

The duration of treatment varies for each child. Some children with mild, intermittent asthma may only need quick-relief medications occasionally. Children with persistent asthma typically need daily controller medications for months or years. Doctors review asthma control regularly, usually every one to six months depending on severity. When asthma has been well controlled for at least three months, doctors may carefully reduce medication doses in a step-down approach to find the minimum effective treatment. If control worsens, treatment is stepped up again.^[17]

Some children’s asthma improves significantly as they grow older, and many can reduce or even stop medications under medical supervision. However, asthma can return, so ongoing monitoring is important. Regular follow-up appointments allow doctors to assess lung function, review symptom control, adjust medications, check inhaler technique, and update the written asthma action plan.^[18]

Innovative Treatments Being Studied in Clinical Trials

While standard treatments work well for most children with asthma, researchers continue investigating new therapies for children whose asthma remains difficult to control despite standard medications. Clinical trials are testing innovative approaches that target specific molecules and pathways involved in asthma inflammation. These studies are conducted in phases to carefully evaluate safety and effectiveness before new treatments become widely available.^[19]

Biologic Therapies

Biologic medications are a newer class of asthma treatments that work by targeting specific components of the immune system involved in airway inflammation. These are typically large protein molecules given by injection or intravenous infusion. Several biologics have been approved for use in children with severe asthma who have not responded adequately to standard treatments. Clinical trials have shown these medications can significantly reduce asthma attacks, improve lung function, and decrease the need for oral corticosteroids in carefully selected patients.^[20]

Omalizumab is a biologic that blocks immunoglobulin E (IgE), an antibody involved in allergic reactions. It is used for children aged 6 years and older with moderate to severe allergic asthma. Clinical trials demonstrated that omalizumab reduces asthma attacks and emergency room visits in children whose asthma is triggered by allergens such as pollen, dust mites, or pet dander. The medication is given by injection every 2 to 4 weeks, with the dose and frequency based on the child’s weight and IgE level measured through blood tests.^[21]

Mepolizumab and reslizumab are biologics that target interleukin-5 (IL-5), a protein that promotes the growth and activity of eosinophils, a type of white blood cell involved in asthma inflammation. These medications are used for children with severe eosinophilic asthma, a specific type of asthma characterized by high levels of eosinophils in the blood or airways. Clinical trials have shown these biologics reduce asthma attacks by up to 50% or more in selected patients. Mepolizumab is given as an injection every 4 weeks, while reslizumab is given as an intravenous infusion every 4 weeks.^[22]

Dupilumab is a biologic that blocks both interleukin-4 (IL-4) and interleukin-13 (IL-13), two proteins that drive type 2 inflammation, a pattern of immune system activity common in allergic asthma and other allergic conditions like eczema. This medication has been studied in clinical trials for children with moderate to severe asthma, particularly those who also have other allergic conditions. Results have shown improvements in lung function, reduced asthma attacks, and better symptom control. Dupilumab is given as an injection every 2 weeks. It was originally developed for eczema and has been adapted for asthma treatment, offering benefits for children with multiple allergic conditions.^[23]

Biologic therapies are generally well tolerated, with the most common side effects being injection site reactions (redness, swelling, or pain where the injection is given). Because these medications affect the immune system, doctors monitor patients for infections and other immune-related effects. These treatments are expensive and typically reserved for children with severe asthma who continue to have frequent attacks or poor control despite using high-dose inhaled corticosteroids and other standard medications correctly.^[24]

Clinical Trial Phases and Participation

New asthma treatments move through several phases of clinical trials before approval. Phase I trials test a new drug in a small group of people (typically adults first) to evaluate safety, determine safe dosage ranges, and identify side effects. Phase II trials involve more participants and focus on evaluating whether the drug is effective for treating asthma while continuing to assess safety. Phase III trials compare the new treatment to standard treatments in large groups of patients to confirm effectiveness, monitor side effects, and collect information that allows the drug to be used safely.^[25]

Children and families may be eligible to participate in clinical trials depending on factors such as the child’s age, asthma severity, current treatments, and other health conditions. Trials are conducted at specialized medical centers in locations including the United States, Europe, and other regions worldwide. Participation in clinical trials offers potential access to new treatments before they are widely available, though there is no guarantee of benefit, and participants may receive placebo (inactive treatment) in some study designs. Families considering trial participation should discuss potential benefits and risks thoroughly with their child’s doctor and the research team.^[26]

Other Innovative Approaches Under Investigation

Researchers are exploring several other promising approaches for childhood asthma treatment. Bronchial thermoplasty is a procedure that uses heat to reduce the amount of smooth muscle in the airways, which may reduce airway narrowing during asthma attacks. While this technique has been studied primarily in adults with severe asthma, research is beginning to evaluate its potential role in older adolescents. The procedure is performed through a bronchoscope (a thin, flexible tube inserted through the nose or mouth into the airways) during three separate sessions.^[27]

Researchers are also investigating new ways to deliver asthma medications more effectively, including improved inhaler devices, smart inhalers that track medication use and provide reminders, and formulations that allow longer-lasting effects with less frequent dosing. Digital health technologies such as smartphone apps that monitor symptoms, track medication use, and provide personalized asthma education are being tested in clinical trials to determine if they improve asthma control and quality of life for children and families.^[28]

Most common treatment methods

• Inhaled bronchodilators
  • Short-acting beta2-agonists like albuterol and levalbuterol provide quick relief of symptoms by relaxing airway muscles
  • Long-acting beta2-agonists such as formoterol and salmeterol provide longer-lasting airway opening when combined with inhaled corticosteroids
  • Anticholinergic medications like ipratropium can be added for severe asthma attacks
  • Delivered through metered-dose inhalers with spacers or nebulizer machines
• Inhaled corticosteroids
  • Most effective long-term controller medications including fluticasone, budesonide, beclomethasone, and mometasone
  • Reduce inflammation and swelling in airways when taken daily
  • Combination inhalers contain both an inhaled corticosteroid and a long-acting beta2-agonist
  • Generally safe with minimal side effects when used at recommended doses
• Leukotriene modifiers
  • Oral medications like montelukast taken once daily as pills or chewable tablets
  • Block leukotrienes, powerful inflammatory chemicals in the body
  • Particularly helpful for allergy-triggered and exercise-induced asthma
  • Can be used alone for mild asthma or added to inhaled corticosteroids
• Systemic corticosteroids
  • Oral or injected steroids such as prednisone, prednisolone, and methylprednisolone
  • Used for short courses (typically 3 to 10 days) during severe asthma attacks
  • Quickly reduce severe inflammation to prevent hospitalizations
  • More potential side effects than inhaled steroids, so reserved for acute situations
• Biologic therapies
  • Omalizumab blocks IgE for children with allergic asthma, given by injection every 2 to 4 weeks
  • Mepolizumab and reslizumab target IL-5 for eosinophilic asthma, reducing asthma attacks by up to 50%
  • Dupilumab blocks IL-4 and IL-13 to reduce type 2 inflammation, given every 2 weeks
  • Reserved for severe asthma not controlled by standard treatments
• Other controller medications
  • Cromolyn sodium and nedocromil are inhaled medications that prevent inflammation with excellent safety profiles
  • Theophylline is an older oral medication that relaxes airways but requires blood level monitoring
  • Used less commonly today due to availability of more effective treatments